Abstract
Thrombophilias are inherited or acquired conditions that predispose an individual to thromboembolism. During pregnancy, maternal thrombophilia has been identified as a major risk factor for adverse pregnancy outcomes (APO), including venous and arterial thrombosis, preeclampsia, placental abruption, intrauterine growth restriction, intrauterine fetal losses and recurrent miscarriages. Although a great body of evidence has accumulated regarding this association, there is still much controversy. In this review, aspects of certain APO and thrombophilia are discussed, as well as prophylactic and therapeutic implications.